Dabigatran vs. Warfarin in the Extended Treatment of VTE - RE-MEDY

Description:

NOTE: See the combined RE-MEDY and RE-SONATE trial update at: http://www.cardiosource.org/Science-And-Quality/Clinical-Trials/R/REMEDY-and-RESONATE.aspx.

Many patients with venous thromboembolism (VTE) require longer-term anticoagulation, sometimes life-long, due to nonmodifiable risk factors. Traditionally, these patients have bee...